ALLOGENEIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Oral pill aims to keep blood cancer at bay after risky transplant
Disease control TerminatedThis study aimed to test if an oral drug called ASTX727, given alone or with an infusion of donor immune cells, could help control blood cancers like leukemia after a stem cell transplant. It was designed for adults who had received a transplant but were at high risk of their can…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug trial aims to keep blood cancers at bay after transplant
Disease control OngoingThis study is testing whether taking the drug ruxolitinib after a stem cell transplant can help prevent cancer from returning in older patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The trial involves 64 participants aged 60-80 who have achieved rem…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC